A Study AnalyZing a NovEl Wearable SeNsor for Remote PatIent Health Monitoring
- Conditions
- Chronic Kidney DiseasesHeart Failure
- Registration Number
- NCT03993886
- Lead Sponsor
- ReThink Medical
- Brief Summary
Evaluate the performance of the CorBand product when used to monitor patients.
- Detailed Description
The goal of the study is to demonstrate the validity and reliability of the CorBand across a suite of six clinical measures by comparing the measurements to similar outputs of FDA cleared devices:
* CorBand heart rate and heart rate variability will be compared to an electrocardiogram.
* CorBand bioimpedance will be compared to recorded extracted fluid and a bioimpedance measurement device.
* CorBand respiration rate will be compared to an respiratory rate sensor.
* CorBand skin temperature will be compared to a skin temperature monitoring device.
* CorBand activity will be compared to an activity monitor.
* CorBand outputs will be compared to the outputs of the CardioMEMS system.
Device safety, comfort, and ease-of-use will also be evaluated as part of this study. Adverse events and serious adverse events will be documented throughout the study duration.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Study Endpoint: Skin Temperature Through study completion, an average of 1 week To evaluate the accuracy of the skin temperature data collected by the CorBand compared to gold standard monitor. (No therapy or health outcomes will be evaluated. Data will assist in developing the decision model using the feature selection for the CorBand algorithm.)
Study Endpoint: Activity Through study completion, an average of 1 week To evaluate the accuracy of the activity (steps/movement) data collected by the CorBand compared to gold standard monitor. (No therapy or health outcomes will be evaluated. Data will assist in developing the decision model using the feature selection for the CorBand algorithm.)
Study Endpoint: Heart Rate Through study completion, an average of 1 week To evaluate the accuracy of the heart rate data collected by the CorBand compared to gold standard monitor. (No therapy or health outcomes will be evaluated. Data will assist in developing the decision model using the feature selection for the CorBand algorithm.)
Study Endpoint: Respiration Rate Through study completion, an average of 1 week To evaluate the accuracy of the respiration rate data collected by the CorBand compared to gold standard monitor. (No therapy or health outcomes will be evaluated. Data will assist in developing the decision model using the feature selection for the CorBand algorithm.)
Study Endpoint: Heart Rate Variability Through study completion, an average of 1 week To evaluate the accuracy of the heart rate variability data collected by the CorBand compared to gold standard monitor. (No therapy or health outcomes will be evaluated. Data will assist in developing the decision model using the feature selection for the CorBand algorithm.)
Study Endpoint: Bioimpedance (Extracellular fluid differences) Through study completion, an average of 1 week To evaluate the accuracy of the bioimpedance (extracellular fluid differences) data collected by the CorBand compared to gold standard monitor. (No therapy or health outcomes will be evaluated. Data will assist in developing the decision model using the feature selection for the CorBand algorithm.)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
University of California, San Francisco
🇺🇸San Francisco, California, United States
Satellite Healthcare
🇺🇸San Jose, California, United States
University of California, San Francisco🇺🇸San Francisco, California, United States